| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.0059 | 1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |